Dosing implications of altered gentamicin disposition in patients with cystic fibrosis
- 1 February 1982
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 100 (2) , 312-318
- https://doi.org/10.1016/s0022-3476(82)80663-x
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- The pathogenesis and treatment of pulmonary infections in patients with cystic fibrosisThe Journal of Pediatrics, 1981
- Intravenous Aminophylline in Patients With Cystic FibrosisAmerican Journal of Diseases of Children, 1980
- A Model for Dosing Gentamicin in Children and Adolescents that Adjusts for Tissue Accumulation with Continuous Dosing1Clinical Pharmacokinetics, 1980
- Multiexponential Elimination of GentamicinDevelopmental Pharmacology and Therapeutics, 1980
- Estimation of kinetic parameters from a two‐point determination of the drug cumulation factorClinical Pharmacology & Therapeutics, 1979
- Clinical Pharmacokinetics of Aminoglycoside AntibioticsClinical Pharmacokinetics, 1979
- Aminoglycoside clearance inpatients with cystic fibrosisThe Journal of Pediatrics, 1979
- Use of gentamicin serum levels to individualize therapy in childrenThe Journal of Pediatrics, 1978
- A model for the prospective identification of the prenephrotoxic state during gentamicin therapyJournal of Pharmacokinetics and Biopharmaceutics, 1978
- Kinetic model for gentamicin dosing with the use of individual patient parametersClinical Pharmacology & Therapeutics, 1977